Anita Singh, DO
Internal Medicine · Miami Beach, FLNPI 1205327244
Payments from drug & device makers
Across 64 payments — averaging $69.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eko Health, Inc.$1K
- Olympus Corporation Of The Americas$845
- AstraZeneca$811
- Insmed, Inc.$229
- Sanofi$131
- Actelion Pharmaceuticals US, Inc.$123
- plus $839 from 12 others
What the payments were for
- Speaking & faculty fees$1,15026%
- Travel & lodging$79218%
- Food & beverage$2,16848%
- Education$170%
- Other$3498%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eko Health, Inc. | 4 | $1,499 |
| Olympus Corporation Of The Americas | 8 | $845 |
| AstraZeneca | 17 | $811 |
| Insmed, Inc. | 8 | $229 |
| Sanofi | 1 | $131 |
| Actelion Pharmaceuticals US, Inc. | 1 | $123 |
| GSK | 5 | $117 |
| Lilly USA, LLC | 2 | $116 |
| Mallinckrodt Hospital Products Inc. | 1 | $114 |
| Viatris Specialty LLC | 4 | $107 |
| Verona Pharma, Inc. | 4 | $104 |
| Harmony Biosciences LLC | 2 | $70 |
| Intuitive Surgical | 1 | $54 |
| UCB, Inc. | 1 | $48 |
| Boehringer Ingelheim | 2 | $48 |
| Merck | 1 | $28 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,477 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $397 |
| Cefazolin Sodium | 11 | $142 |
| Fluticasone Propionate | 12 | $79 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Miami Beach
- Gene NeytmanMiami Beach$4.4M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.